Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aerosol 13-cis-Retinoic Acid and Captopril for COVID-19
NCT04578236Phase 2Unknown
- Sponsor
- Kafrelsheikh University
- Start
- Nov 2020
- Primary completion
- Dec 2020
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of isotretinoin, captopril in coronavirus disease 2019 (COVID-19), sponsored by Kafrelsheikh University. Status: unknown.
02
Drugs
isotretinoincaptopril
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04578236.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04578236.